Primary Biliary Cirrhosis: What do autoantibodies tell us?

59Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Primary biliary cirrhosis (PBC) is a chronic, progressive, cholestatic, organ-specific autoimmune disease of unknown etiology. It predominantly affects middle-aged women, and is characterized by autoimmune-mediated destruction of small- and medium-size intrahepatic bile ducts, portal inflammation and progressive scarring, which without proper treatment can ultimately lead to fibrosis and hepatic failure. Serum autoantibodies are crucial tools for differential diagnosis of PBC. While it is currently accepted that antimitochondrial antibodies are the most important serological markers of PBC, during the last five decades more than sixty autoantibodies have been explored in these patients, some of which had previously been thought to be specific for other autoimmune diseases. © 2010 Baishideng.

Cite

CITATION STYLE

APA

Hu, C. J., Zhang, F. C., Li, Y. Z., & Zhang, X. (2010). Primary Biliary Cirrhosis: What do autoantibodies tell us? World Journal of Gastroenterology. Baishideng Publishing Group Co. https://doi.org/10.3748/wjg.v16.i29.3616

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free